What’s the down time? St Emlyn’s
There is one question that is always asked when a patient who has experienced a cardiac arrest is brought to the ED. What’s the downtime? (Nearly) Every team leader in […]
What’s the down time? St Emlyn’s Read More
dom9
Alternate defibrillation strategies in refractory ventricular fibrillation
Review of an RCT comparing dual sequence defibrillation against antero-lateral and antero-posterior pad positions
Alternate defibrillation strategies in refractory ventricular fibrillation Read More
JC: Fentanyl as an adjunct in RSI. Does it affect haemodynamic stability? St Emlyn’s
I’ve recently been spending a bit more time in the pre-hospital environment and it’s been interesting to compare practice there as compared to the emergency department. One theme has been
JC: Fentanyl as an adjunct in RSI. Does it affect haemodynamic stability? St Emlyn’s Read More
JC: Head up, mechanical and impedance device assisted CPR – does it make a difference? St Emlyn’s
Research in cardiac arrest management has improved a lot in recent years. We are now seeing large randomised controlled trials looking at specific therapies in the management of these critically
TBI: The Final Frontier…
Summer hols and quiet times for many of us at present, so apologies for lack of posts. There is always stuff going on in the background however, and several of
TBI: The Final Frontier… Read More
More on Calcium and blood products in trauma. St Emlyn’s
This week we have a nice paper that highlights some of the ongoing thoughts and controversies about the use of calcium in major haemorrhage protocols. Hopefully you’ve already read Iain’s
More on Calcium and blood products in trauma. St Emlyn’s Read More
Podcast – June/July 2022 Monthly Round Up
Iain and Simon run through the best of the blog from June and July 2022.
Podcast – June/July 2022 Monthly Round Up Read More
Baricitinib for hospitalised COVID19 patients. St Emlyn’s
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More